Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -123.91%-415K | -110.46%-274K | -45.63%1.74M | 217.76%2.62M | 799.44%3.19M | -28.04%-2.22M | -80.26%355K | -264.33%-1.74M | 37.46%1.8M | 110.52%1.06M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -13.17%-318K | -64.94%-762K | -13.31%-281K | -294.87%-462K | -8,166.67%-248K | -3,800.00%-117K | 0.00%-3K | 98.26%-3K | 98.11%-3K | ---172K |
| Attributable subsidiary (profit) loss | -75.00%1K | -40.00%6K | -33.33%4K | 42.86%10K | -14.29%6K | -56.25%7K | -22.22%7K | 145.71%16K | 800.00%9K | -369.23%-35K |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 215.01%1.32M | 357.42%2.95M | -124.64%-1.15M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 27.18%-75K |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 223.06%1.32M | 375.44%2.95M | -139.83%-1.07M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.45%1K | ---- | ---221K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---243K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -95.45%1K | ---- | --22K |
| Depreciation and amortization: | -6.87%1.52M | -27.73%3.07M | -8.01%1.63M | 107.63%4.24M | 101.02%1.77M | 67.68%2.04M | 43.41%882K | -37.46%1.22M | -33.15%615K | 13.98%1.95M |
| -Other depreciation and amortization | -5.46%1.42M | -28.95%2.82M | -7.51%1.5M | 125.54%3.97M | 121.09%1.63M | 75.62%1.76M | 35.86%735K | -44.82%1M | -36.43%541K | 62.84%1.81M |
| Financial expense | -36.54%370K | 6.98%1.06M | 50.26%583K | 33.29%989K | -13.00%388K | -26.24%742K | -18.91%446K | -41.92%1.01M | -67.20%550K | -32.61%1.73M |
| Operating profit before the change of operating capital | -68.50%1.16M | -58.18%3.1M | -28.15%3.67M | 1,537.17%7.4M | 203.02%5.11M | -75.16%452K | -71.50%1.69M | -42.48%1.82M | 148.70%5.92M | 387.11%3.16M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -67.42%144K |
| Accounts receivable (increase)decrease | -59.15%12.4M | 139.10%15.04M | 758.61%30.36M | -75.14%-38.46M | 71.70%-4.61M | -123.16%-21.96M | -200.41%-16.29M | 275.48%94.8M | -139.33%-5.42M | -28.68%-54.02M |
| Accounts payable increase (decrease) | 61.41%-14.27M | -161.18%-21.62M | -1,221.16%-36.98M | 46.70%35.34M | -87.30%3.3M | 129.78%24.09M | 27.37%25.98M | -279.55%-80.89M | 586.52%20.4M | 23.55%45.05M |
| prepayments (increase)decrease | 29.27%-2.2M | -4,591.30%-1.08M | 27.40%-3.11M | -276.92%-23K | 72.12%-4.28M | -96.49%13K | -3,916.49%-15.34M | 209.79%370K | -687.69%-382K | -137.03%-337K |
| Special items for working capital changes | -68.94%2.67M | 199.92%13.85M | 1,163.37%8.59M | -234.19%-13.86M | -124.18%-808K | -2,811.11%-4.15M | 142.99%3.34M | -99.17%153K | -152.35%-7.77M | 207.13%18.36M |
| Cash from business operations | -109.35%-238K | 196.68%9.29M | 297.90%2.55M | -518.81%-9.6M | -104.78%-1.29M | -109.55%-1.55M | -104.93%-628K | 31.36%16.25M | -52.89%12.74M | 155.20%12.37M |
| Hong Kong profits tax paid | -180.00%-24K | -1,211.11%-300K | 372.73%30K | -74.29%27K | ---11K | 126.45%105K | ---- | -694.00%-397K | 97.44%-1K | -4,900.00%-50K |
| Interest received - operating | 19.27%328K | 59.40%746K | 9.13%275K | 354.37%468K | 8,300.00%252K | 3,333.33%103K | 0.00%3K | -98.26%3K | -98.25%3K | -84.29%172K |
| Net cash from operations | -97.68%66K | 206.83%9.73M | 372.73%2.85M | -577.75%-9.11M | -67.20%-1.05M | -108.48%-1.34M | -104.91%-625K | 26.92%15.85M | -53.12%12.74M | 158.14%12.49M |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --24K |
| Purchase of fixed assets | -300.00%-4K | ---31K | ---1K | ---- | ---- | 96.65%-6K | 95.15%-5K | -193.44%-179K | ---103K | 55.80%-61K |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --13.19M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 102.62%500K |
| Net cash from investment operations | -300.00%-4K | ---31K | ---1K | ---- | ---- | 96.65%-6K | 95.15%-5K | -101.31%-179K | -100.78%-103K | 171.41%13.65M |
| Net cash before financing | -97.82%62K | 206.49%9.7M | 372.63%2.85M | -574.74%-9.11M | -65.87%-1.05M | -108.61%-1.35M | -104.99%-630K | -40.05%15.67M | -68.71%12.63M | 164.39%26.14M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | --474K | --10.26M | ---- | ---- | ---- | ---- | ---- | -70.00%13.48M |
| Refund | ---- | ---4.23M | ---1.54M | ---- | ---- | 94.13%-889K | 96.50%-508K | 77.43%-15.14M | 77.03%-14.5M | -2,311.21%-67.08M |
| Interest paid - financing | 35.88%-370K | -7.01%-1.05M | -72.24%-577K | -31.38%-984K | 31.07%-335K | 31.97%-749K | 19.67%-486K | 53.15%-1.1M | 53.46%-605K | 12.93%-2.35M |
| Absorb investment income | ---- | ---- | ---- | 50.00%300K | --300K | --200K | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --32.1M |
| Net cash from financing operations | 74.03%-453K | -158.54%-5.49M | -1,172.99%-1.74M | 685.99%9.37M | 87.40%-137K | 90.23%-1.6M | 92.83%-1.09M | 31.68%-16.36M | 53.17%-15.16M | -160.71%-23.95M |
| Effect of rate | 200.00%2K | 37.50%-5K | 88.24%-2K | 79.49%-8K | 56.41%-17K | -4,000.00%-39K | -657.14%-39K | -97.22%1K | 75.00%7K | 123.38%36K |
| Net Cash | -135.38%-391K | 1,514.94%4.22M | 193.49%1.11M | 108.85%261K | 31.16%-1.18M | -329.26%-2.95M | 31.92%-1.72M | -131.26%-687K | -131.46%-2.52M | 289.16%2.2M |
| Begining period cash | 35.77%15.98M | 2.20%11.77M | 2.20%11.77M | -20.60%11.52M | -20.60%11.52M | -4.52%14.5M | -4.52%14.5M | 17.24%15.19M | 17.24%15.19M | -9.22%12.96M |
| Cash at the end | 21.12%15.59M | 35.77%15.98M | 24.76%12.87M | 2.20%11.77M | -19.07%10.32M | -20.60%11.52M | 0.58%12.75M | -4.52%14.5M | -39.57%12.68M | 17.24%15.19M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.40%2.16M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.40%2.16M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.